CURRENT MEDICATIONS OVERVIEW,,
MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST
"Escitalopram(Lexapro)",CYP2C19,Major – significant result that may require altering this medication
MEDICATIONS WITH MAJOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"ADHD -miscellaneous agents",Atomoxetine,CYP2D6,Adverse effects,FDA2
Antiarrhythmics,Flecainide,CYP2D6,Adverse effects,DPWG3
"",Propafenone,CYP2D6,Adverse effects,DPWG3
"Anticholinergics(genitourinary)",Tolterodine,CYP2D6,Adverse effects,FDA4
"Antidepressants -other",Vortioxetine,CYP2D6,Adverse effects,"TGA5, FDA6"
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Venlafaxine,CYP2D6,Adverse effects,DPWG3
"Antidepressants -SSRIs",Citalopram,CYP2C19,Reduced / inadequate response,CPIC1
"",Escitalopram,CYP2C19,Reduced / inadequate response,CPIC1
"",Fluoxetine,"CYP2D6CYP2C9",Adverse effects,FDA7
"",Fluvoxamine,"CYP2D6CYP1A2",Adverse effects,CPIC1
"",Paroxetine,CYP2D6,Adverse effects,CPIC1
"Antidepressants -tricyclicantidepressants",Amitriptyline,"CYP2D6CYP2C19",Altered response,CPIC8
"",Clomipramine,"CYP2D6CYP2C19",Altered response,CPIC8
"",Desipramine,CYP2D6,Adverse effects,CPIC8
"",Doxepin,"CYP2D6CYP2C19",Altered response,CPIC8
"",Imipramine,"CYP2D6CYP2C19",Altered response,CPIC8
"",Nortriptyline,CYP2D6,Adverse effects,CPIC8
Antiemetics,Ondansetron,CYP2D6,"Increased therapeutic and/oradverse effects",CPIC9
Antifungals - Azoles,Voriconazole,CYP2C19,Reduced / inadequate response,CPIC10
MEDICATIONS WITH MAJOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
Antipsychotics,Aripiprazole,CYP2D6,Adverse effects,"DPWG3,TGA11, FDA12"
"",Brexpiprazole,CYP2D6,Adverse effects,FDA13
"",Haloperidol,CYP2D6,Adverse effects,DPWG
"",Pimozide,CYP2D6,Adverse effects,FDA14
"",Risperidone,CYP2D6,Adverse effects,DPWG3
"",Zuclopenthixol,CYP2D6,Adverse effects,DPWG3
Antitussives,Dextromethorphan,CYP2D6,Adverse effects,-
Beta blockers,Metoprolol,CYP2D6,Adverse effects,DPWG3
"Glaucoma - ocularpreparations",Timolol,CYP2D6,Adverse effects,-
"Immunomodulatorsand antineoplastics",Tamoxifen,CYP2D6,Reduced / inadequate response,CPIC15
Miscellaneous,Eliglustat,CYP2D6,Adverse effects,TGA16
Neurological drugs,Tetrabenazine,CYP2D6,"Increased therapeutic andadverse effects",FDA17
Opioid Analgesics,Codeine,"CYP2D6OPRM1",Reduced / inadequate response,CPIC18
Hydrocodone,CYP2D6,Reduced / inadequate response,,
Tramadol,CYP2D6,Reduced / inadequate response,DPWG3,
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Anticholinergics(genitourinary)",Darifenacin,CYP2D6,Adverse effects,-
"",Fesoterodine,CYP2D6,Adverse effects,-
Anticholinesterases,Donepezil,CYP2D6,Adverse effects,-
"",Galantamine,CYP2D6,Adverse effects,-
"Antidepressants -other",Mirtazapine,"CYP2D6CYP1A2",Adverse effects,-
"",Moclobemide,CYP2C19,Reduced / inadequate response,-
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Duloxetine,"CYP2D6CYP1A2",Adverse effects,-
"Antidepressants -SSRIs",Sertraline,CYP2C19,Reduced / inadequate response,CPIC1
Antidiabetics,Gliclazide,"CYP2C9CYP2C19",Reduced / inadequate response,-
Antiemetics,Metoclopramide,CYP2D6,Adverse effects,-
Antihistamines,Chlorpheniramine,CYP2D6,Adverse effects,-
"",Dexchlorpheniramine,CYP2D6,Adverse effects,-
"",Promethazine,CYP2D6,Adverse effects,-
Antiplatelet drugs,Clopidogrel,CYP2C19,Adverse effects,CPIC19
Antipsychotics,Chlorpromazine,CYP2D6,Adverse effects,-
Benzodiazepines,Clobazam,CYP2C19,Reduced / inadequate response,-
"",Diazepam,CYP2C19,Reduced / inadequate response,-
Beta blockers,Carvedilol,CYP2D6,Adverse effects,-
Nebivolol,CYP2D6,Adverse effects,-,
Propranolol,"CYP2D6CYP1A2",Adverse effects,-,
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
Miscellaneous,Cyclophosphamide,CYP2C19,"Increased therapeutic and/oradverse effects",-
"",Proguanil,CYP2C19,Altered response,-
Opioid Analgesics,Morphine,OPRM1,"Associated with reducedresponse to morphine",-
"",Oxycodone,CYP2D6,Reduced / inadequate response,DPWG3
"Proton pumpinhibitors",Dexlansoprazole,CYP2C19,Reduced / inadequate response,-
"",Esomeprazole,CYP2C19,Reduced / inadequate response,-
"",Lansoprazole,CYP2C19,Reduced / inadequate response,-
"",Omeprazole,CYP2C19,Reduced / inadequate response,-
"",Pantoprazole,CYP2C19,Reduced / inadequate response,-
"",Rabeprazole,CYP2C19,Reduced / inadequate response,-
Psychostimulants,Dextroamphetamine,CYP2D6,Adverse effects,-
Lisdexamfetamine,CYP2D6,Adverse effects,-,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Angiotensin receptorblockers",Irbesartan,CYP2C9,"No altered effect predicted bygenotype",-
"",Losartan,CYP2C9,"No altered effect predicted bygenotype",-
Anticoagulants,Acenocoumarol,"VKORC1CYP2C9",Normal acenocoumarol sensitivity,
"",Warfarin,"VKORC1CYP2C9",Normal warfarin sensitivity,FDA20
Antidiabetics,Glimepiride,CYP2C9,"No altered effect predicted bygenotype",-
"",Glyburide,CYP2C9,"No altered effect predicted bygenotype",-
Antiepileptics,Phenytoin,CYP2C9,"No altered effect predicted bygenotype",CPIC21
Antipsychotics,Clozapine,CYP1A2,"No altered effect predicted bygenotype",-
"",Olanzapine,CYP1A2,"No altered effect predicted bygenotype",-
"",Quetiapine,CYP3A4,"No altered effect predicted bygenotype",-
Calcineurin inhibitors,Tacrolimus,CYP3A5,"No altered effect predicted bygenotype",CPIC22
Hypnotics,Melatonin,CYP1A2,"No altered effect predicted bygenotype",-
Miscellaneous,Atazanavir,CYP3A5,"No altered effect predicted bygenotype",-
"",Naltrexone,OPRM1,"No altered effect predicted bygenotype for naltrexone",
NSAIDs,Celecoxib,CYP2C9,"No altered effect predicted bygenotype",-
Diclofenac,CYP2C9,"No altered effect predicted bygenotype",-,
Flurbiprofen,CYP2C9,"No altered effect predicted bygenotype",-,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"",Ibuprofen,CYP2C9,"No altered effect predicted bygenotype",-
"",Indomethacin,CYP2C9,"No altered effect predicted bygenotype",-
"",Mefenamic Acid,CYP2C9,"No altered effect predicted bygenotype",-
"",Meloxicam,CYP2C9,"No altered effect predicted bygenotype",-
"",Piroxicam,CYP2C9,"No altered effect predicted bygenotype",-
Statins,Atorvastatin,"SLCO1B1CYP3A4","No altered effect predicted bygenotype",-
Fluvastatin,"SLCO1B1CYP2C9","No altered effect predicted bygenotype",-,
Pravastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
Rosuvastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
Simvastatin,"SLCO1B1CYP3A4","No altered effect predicted bygenotype",CPIC23,
